VTRS Viatris
- Official Name: VIATRIS INC.
- Headquarters: 1000 Mylan Boulevard, CANONSBURG, PA, 15317 US
- CEO: Scott Smith
- Website: viatris.com
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-15 | 1R | Won by 0.114 | (1.148) - (1.262) | ||
| 2025-07-17 | 1 | Lost by 0.035 | 3.539 - 3.574 | ||
| 2025-07-23 | 1R | Won by 0.041 | 1.375 - 1.334 | ||
| 2025-07-24 | 2 | Lost by 3.762 | 1.848 - 5.610 | ||
| 2025-07-29 | 2R | Lost by 7.392 | (1.790) - 5.602 | ||
| 2025-07-31 | 3 | Lost by 11.733 | (7.735) - 3.998 | ||
| 2025-08-06 | 2R | Lost by 1.695 | (2.228) - (0.533) | ||
| 2025-08-07 | 4 | Won by 11.440 | 8.268 - (3.172) | ||
| 2025-08-07 | 1R | Won by 4.827 | 6.554 - 1.727 | ||
| 2025-08-14 | 5 | Won by 17.683 TOTW | 13.980 - (3.703) | ||
| 2025-08-21 | 6 | Won by 0.012 | 1.044 - 1.032 | ||
| 2025-08-21 | 2R | Won by 0.742 | 0.435 - (0.307) | ||
| 2025-08-28 | 7 | Won by 0.629 | (2.701) - (3.330) | ||
| 2025-09-04 | 8 | Won by 0.182 | (0.752) - (0.934) | ||
| 2025-09-04 | 3R | Lost by 3.349 | (2.092) - 1.257 | ||
| 2025-09-11 | 9 | Lost by 2.434 | (1.547) - 0.887 | ||
| 2025-09-18 | 10 | Won by 1.323 | (3.084) - (4.407) | ||
| 2025-09-25 | 11 | Won by 2.440 | (3.162) - (5.602) | ||
| 2025-10-02 | 12 | Won by 7.262 TOTW | 6.391 - (0.871) | ||
| 2025-10-09 | 13 | Lost by 6.316 | (1.195) - 5.121 | ||
| 2025-10-16 | 14 | Won by 0.182 | 1.094 - 0.912 | ||
| 2025-10-23 | 15 | Won by 1.715 | 2.396 - 0.681 |
Latest News
Yahoo - 2026-10-16
Viatris Receives U.S. FDA Approval for RYZUMVI® for the Treatment of Presbyopia
Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has approved RYZUMVI® (phe...
Yahoo - 2026-10-16
Opus Genetics Secures FDA Approval For Eye Drops – Set To Receive Milestone Payment
The approval expands the therapy's use and triggers a milestone payment from commercial partner Viatris.
Yahoo - 2026-10-16
Opus Genetics Announces FDA Approval of Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia
FDA expands the approved use of phentolamine ophthalmic solution 0.75% to include age-related near vision impairment, which affects millions of adults...
SeekingAlpha - 2026-10-16
Biogen: The Bull Case Is Extending Beyond Alzheimer's (Rating Upgrade)
Biogen's Q3 earnings are due Oct 28. Explore FY2026 EPS guidance, Alzheimerâs revenue growth, and key risk/reward driversâread now. Cli...
ChartMill - 2026-10-14
Exploring the top movers within the S&P500 index during today's session.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wed...
SeekingAlpha - 2026-10-12
Viatris: Is The Pacira Deal A Game Changer? (Rating Upgrade)
Viatris Q3 earnings preview: raised 2026 EPS guidance, improving margins, and Pacira acquisition impact.
Yahoo - 2026-10-12
Stocktwits M&A Watch: Viatris-Pacira Deal, Coca-Cola’s Costa Coffee Sale, Devon’s Eagle Ford Divestiture In Focus
Wall Street is abuzz with deal chatter as major healthcare, beverage, and oil companies eye significant deals in the coming weeks.
SeekingAlpha - 2026-10-12
Viatris: Improved Confidence Drives M&A Action Again
Viatris has rebounded 50% YTD, driven by a return to growth and operating leverage after years of stagnation and execution issues. I rate the VTRS sto...
Show more
Yahoo - 2026-10-09
Stocktwits Biotech Dealmaker — Viatris And GE Healthcare Buy What They Can Sell; Biohaven And Alector Sell Rights
Benzinga - 2026-10-09
Deal Dispatch: Uber Buys ezCater For $2.3B, Skydance Takes Over Warner Bros., True Food Kitchen Bankruptcy
Yahoo - 2026-10-09
Viatris to Buy Pacira for $1.65B to Expand Non-Opioid Pain Portfolio
Benzinga - 2026-10-09
How Your Taxes Will Be Different Next Year, And Why You'll Have Trump To Thank
SeekingAlpha - 2026-10-09
Viatris To Acquire Pacira BioSciences: What Investors Should Know
SeekingAlpha - 2026-10-09
Buy Any Of 15 Ideal 'Safer' October Dogs Tenured Over 10 Years
Yahoo - 2026-10-09
Viatris (VTRS) Buys Pacira As Fair Value Stays In Focus
Yahoo - 2026-10-08
Could an FDA Nod for MR-141 Give Viatris (VTRS) and Opus Genetics (IRD) a Presbyopia Payoff?
Yahoo - 2026-10-08
Sector Update: Healthcare Stocks Softer Late Afternoon
Yahoo - 2026-10-08
Viatris to acquire Pacira BioSciences for $1.65 billion
Yahoo - 2026-10-08
Why Is Viatris (VTRS) Expanding Its Non Opioid Pain Portfolio Now?
Yahoo - 2026-10-08
HAE, PCRX Stocks Hit Multi-Year Highs Amid Broader Market Selloff – What’s Driving The Momentum Today?
Yahoo - 2026-10-08
Why Pacira BioSciences Stock Is Having Its Best Day Ever After $1.7 Billion Viatris Acquisition
Yahoo - 2026-10-08
Viatris makes foray into non-opioid pain space on $1.65bn Pacira buyout
Yahoo - 2026-10-08
Viatris Agrees to Acquire Pacira BioSciences in $1.65 Billion Deal
Yahoo - 2026-10-08
Viatris boosts pain drug portfolio with $1.7B buyout of Pacira
Yahoo - 2026-10-08
Why Pacira BioSciences Skyrocketed Today
Yahoo - 2026-10-08
2 Stocks Drawing Bearish Options Activity Today
Yahoo - 2026-10-08
Pacira Biosciences Snags $1.65 Billion Viatris Takeover Deal; Shares Fly
Yahoo - 2026-10-08
Viatris Agrees to Acquire Pacira BioSciences for $1.65 Billion in Non-Opioid Pain Therapy Expansion
Benzinga - 2026-10-08
Viatris Bets Big on Non-Opioid Painkillers With Pacira Buyout
ChartMill - 2026-10-08
These S&P500 stocks that are showing activity before the opening bell on Thursday.
Yahoo - 2026-10-08
Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies
Yahoo - 2026-10-06
VTRS vs. AVTR: Which Stock Is the Better Value Option?
Yahoo - 2026-10-06
Should Value Investors Buy Viatris (VTRS) Stock?
Benzinga - 2026-10-05
UBS Maintains Buy on Viatris, Raises Price Target to $26
Yahoo - 2026-10-05
FDA Decision Watch: RHHBY, VTRS And IRD Face Key October Drug Rulings As MRK Withdraws Application
Yahoo - 2026-10-05
Harrow Closes Acquisition of TYRVAYA®
SeekingAlpha - 2026-09-30
Aquestive Therapeutics: The Market Is Already Pricing In Anaphylam's Success
Yahoo - 2026-09-29
Viatris Recognized by Forbes as One of the World's Best Employers for the Sixth Consecutive Year
ChartMill - 2026-09-28
Stay informed with the top movers within the S&P500 index on Monday.
Yahoo - 2026-09-25
Viatris sues Novo Nordisk over generic Wegovy patent dispute
Yahoo - 2026-09-24
Is Viatris Stock Outperforming the S&P 500?
Benzinga - 2026-09-23
Oppenheimer Initiates Coverage On Viatris with Outperform Rating, Announces Price Target of $25
Benzinga - 2026-09-23
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks Delivering High-Dividend Yields
Yahoo - 2026-09-20
Viatris (VTRS) Wins Japan WAKIX Approval. Can it Build a Meaningful Specialty Business?
Yahoo - 2026-09-19
3 US Stocks That Could Gain If Buyers Shift Away From India
Yahoo - 2026-09-16
Gilead Expands Lenacapavir Licensing Agreements to Include Once-Yearly HIV Prevention Formulation
Benzinga - 2026-09-16
Piper Sandler Maintains Neutral on Viatris, Raises Price Target to $13
Benzinga - 2026-09-16
Viatris Secures Japan Approval For WAKIX In Treating Excessive Daytime Sleepiness Linked To Sleep Apnea And Narcolepsy
Yahoo - 2026-09-14
3 Healthcare Stocks That Fall Short
SeekingAlpha - 2026-09-09
Viatris: Strong Cash Generation And Pipeline Progress Keep The Re-Rating Story Alive
Benzinga - 2026-09-09
Leerink Partners Initiates Coverage On Viatris with Outperform Rating, Announces Price Target of $20
Benzinga - 2026-09-08
Argus Research Maintains Buy on Viatris, Raises Price Target to $20
Yahoo - 2026-09-02
Billionaire Portfolios: 2 Under-$20 Healthcare Stock Picks
Yahoo - 2026-08-31
3 Cash-Producing Stocks That Concern Us
Yahoo - 2026-08-29
Viatris (VTRS) Faces Fresh Generic Earnings Questions, Is The 12% Discount Enough?
SeekingAlpha - 2026-08-28
17 Ideal 'Safer' Buyable August Dogs Dug Up After 10 Years
Yahoo - 2026-08-28
Cavendish reiterates 'buy' rating on Shield Therapeutics after US deal with Viatris
Yahoo - 2026-08-27
3 Generic Drug Stocks to Watch Amid Improving Industry Trends
Yahoo - 2026-08-25
The Real Engine That Could Power Tesla Stock Higher
Yahoo - 2026-08-25
Dell Stock's Massive Guidance Raise Has A Catch
Yahoo - 2026-08-19
Viatris' China Policy Concerns Overstated, UBS Says
Yahoo - 2026-08-19
3 S&P 500 Stocks We Keep Off Our Radar
Yahoo - 2026-08-18
3 Stocks Under $50 We’re Skeptical Of
Yahoo - 2026-08-15
5 Must-Read Analyst Questions From Viatris’s Q2 Earnings Call
Yahoo - 2026-08-13
Viatris (VTRS) is Selling Tyrvaya, but Could Harrow (HROW) Turn it Into a Growth Engine?
Yahoo - 2026-08-13
Viatris (VTRS) Q2 2026 Earnings Call Transcript
SeekingAlpha - 2026-08-12
Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio: Q2 2026 Update
Yahoo - 2026-08-12
Is AMRX Stock a Buy as Growth Improves but Execution Risks Persist?
Yahoo - 2026-08-11
TBPH Meets Q2 Earnings Estimates, to be Acquired by Zymeworks
Yahoo - 2026-08-11
VTRS Q2 Deep Dive: China Growth, Pipeline Progress, and Margin Concerns Shape Outlook
Yahoo - 2026-08-09
Viatris (VTRS) Is Down 6.4% After Raising 2026 Guidance And Completing Major Buyback Program
Yahoo - 2026-08-09
Viatris (VTRS) Stock May Be Below Fair Value Despite FDA Patch Approval
Yahoo - 2026-08-09
Viatris (VTRS) Stock Sees Modest Fair Value Lift After Q1 Results And Pipeline Progress
Yahoo - 2026-08-06
Viatris Inc (VTRS) (Q2 2026) Earnings Call Highlights: Strong Growth and Raised Guidance Amid ...
SeekingAlpha - 2026-08-06
Viatris Inc. (VTRS) Q2 2026 Earnings Call Transcript
Yahoo - 2026-08-06
VTRS Q2 Earnings Beat, Revenues Rise 5% as Greater China Sales Jump
Benzinga - 2026-08-06
Viatris Sharpens Focus with Divestiture, Hikes 2026 Outlook
SeekingAlpha - 2026-08-06
Viatris Inc. 2026 Q2 - Results - Earnings Call Presentation
Yahoo - 2026-08-06
Compared to Estimates, Viatris (VTRS) Q2 Earnings: A Look at Key Metrics
Yahoo - 2026-08-06
Viatris (VTRS) Beats Q2 Earnings and Revenue Estimates
Yahoo - 2026-08-06
Viatris (NASDAQ:VTRS) Posts Better-Than-Expected Sales In Q2 CY2026
Yahoo - 2026-08-06
Harrow Acquires Global Rights to TYRVAYA®, the First and Only FDA-Approved Nasal Spray for Dry Eye Disease
Yahoo - 2026-08-06
Viatris Reports Second-Quarter 2026 Financial Results
Benzinga - 2026-08-06
Viatris Q2 Adj. EPS $0.69 Beats $0.60 Estimate, Sales $3.756B Beat $3.675B Estimate
Benzinga - 2026-08-06
Viatris Raises FY2026 Adj EPS Guidance from $2.33-$2.47 to $2.45-$2.49 vs $2.44 Est; Raises FY2026 Sales Guidance from $14.450B-$14.950B to $14.550B-$14.950B vs $14.783B Est
SeekingAlpha - 2026-08-05
Teva Pharmaceuticals: Continuing To Execute On Its 'Pivot To Growth' Plan
Yahoo - 2026-08-05
Viatris (VTRS) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Yahoo - 2026-08-05
CVS Health (CVS) Q2 Earnings and Revenues Beat Estimates
Yahoo - 2026-08-04
Viatris Gears Up to Report Q2 Earnings: What's in the Cards?
Yahoo - 2026-08-04
Is Wall Street Bullish or Bearish on Viatris Stock?
Yahoo - 2026-08-04
Viatris Announces Quarterly Dividend
Yahoo - 2026-08-03
GeneDx Holdings Corp. (WGS) Q2 Earnings and Revenues Surpass Estimates
SeekingAlpha - 2026-08-03
Viatris: A Reasonable Valuation
Yahoo - 2026-08-02
Viatris (VTRS) Wins FDA Approval For Gwyn Lo Contraceptive Patch
SeekingAlpha - 2026-07-31
Low Growth Viatris Is Due For A Pullback After A Stellar 16-Month Run
Yahoo - 2026-07-30
Viatris (VTRS) Q2 Earnings Preview: What's in the Cards?
Yahoo - 2026-07-29
Viatris Receives U.S. FDA Approval for Gwyn Lo™, a Once-Weekly Contraceptive Patch
SeekingAlpha - 2026-07-29
18 Ideal 'Safer' Buyable July Dogs Emerge After 10 Years Of Digging
Yahoo - 2026-07-28
Generic Pharmaceuticals Stocks Q1 Highlights: Viatris (NASDAQ:VTRS)
Yahoo - 2026-07-24
3 Healthcare Stocks We Keep Off Our Radar
Benzinga - 2026-07-24
Viatris Receives EMA CHMP Recommendation For Approval Of Ruxolitinib Viatris For The Treatment Of Myelofibrosis, Polycythaemia Vera And Graft-Vs-Host Disease
Yahoo - 2026-07-22
Trump Proposes 200% Generic Drug Tariffs, Sandoz Shares Drop 4.2%
Yahoo - 2026-07-22
Viatris’ Quarterly Earnings Preview: What You Need to Know
CNBC - 2026-07-22
Trump's generic drug tariffs: What they could mean for medicine prices, manufacturers and supply
Yahoo - 2026-07-20
3 Unpopular Stocks We’re Skeptical Of
Yahoo - 2026-07-17
Financial Stocks Rally To New Highs. JPMorgan Is One Of Them.
SeekingAlpha - 2026-07-14
Organon & Co: Great Odds, Small Prize, Big Penalty
Benzinga - 2026-07-14
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Yahoo - 2026-07-09
VTRS or DHR: Which Is the Better Value Stock Right Now?
Yahoo - 2026-07-09
Systemic Lupus Erythematosus Market at a Turning Point as 6 Late-Stage Emerging Therapies Set to Redefine Treatment Landscape | DelveInsight
Yahoo - 2026-07-07
3 Dirt Cheap Healthcare Shares Under $30 to Buy Right Now
Yahoo - 2026-07-06
Should Viatris’ Japan IgA Nephropathy Win and New Loan Shape VTRS Investors’ Next Move?
Yahoo - 2026-07-05
Viatris (VTRS) Secures Loan Amid Positive Phase 3 Results
Yahoo - 2026-07-05
Viatris (VTRS): Most Undervalued NASDAQ Stocks to Buy Right Now
Yahoo - 2026-07-02
Viatris (VTRS) is a Great Momentum Stock: Should You Buy?
Yahoo - 2026-06-30
Theravance Stock Down 3% After Zymeworks Announces Buyout
Yahoo - 2026-06-29
Viatris Announces Positive Top-Line Results from Phase 3 Study of VR-205 in Japanese Adults with Primary Immunoglobulin A Nephropathy
Benzinga - 2026-06-29
Viatris’ VR‑205 Phase 3 Trial in Japan Met Primary and Key Secondary Endpoints; Safety Profile Aligned With Global Studies, NDA Filing Planned by End‑2026
Yahoo - 2026-06-23
VTRS vs. DHR: Which Stock Is the Better Value Option?
Yahoo - 2026-06-23
Are Investors Undervaluing Viatris (VTRS) Right Now?
SeekingAlpha - 2026-06-23
Viatris Soared 54%: Time To Be More Careful (Rating Downgrade)
Yahoo - 2026-06-19
How Is Viatris’ Stock Performance Compared to Other Healthcare Stocks?
Yahoo - 2026-06-18
FDA Seeks Updated Labeling for Testosterone Therapies
Yahoo - 2026-06-16
1 Cash-Producing Stock with Exciting Potential and 2 Facing Headwinds
Yahoo - 2026-06-16
Viatris Recognized as One of the 2026 Best Workplaces™ in Canada
Yahoo - 2026-06-14
Viatris (VTRS) Stock And The 58% Undervaluation Debate After A Strong Year Of Returns
Yahoo - 2026-06-14
Viatris Euro Debt Raise Reshapes Capital Structure And Valuation Story
Yahoo - 2026-06-11
Lexicon Pharmaceuticals vs. Pfizer: Which Drugmaker Stock Is a Better Buy in 2026?
Yahoo - 2026-06-05
3 Generic Drug Stocks to Watch as New Growth Drivers Emerge
Yahoo - 2026-06-03
How Is Zoetis’ Stock Performance Compared to Other Healthcare Stocks?
SeekingAlpha - 2026-05-28
90 Top Ten-Year Dog Collection Yields 22 Ideal Buys From 41 'Safer' Sorts In May
Yahoo - 2026-05-24
Assessing Viatris (VTRS) Valuation After FDA Review Acceptance For Fast Acting Non Opioid Meloxicam
Yahoo - 2026-05-23
1 Unpopular Stock That Should Get More Attention and 2 We Find Risky
Yahoo - 2026-05-21
Viatris (VTRS): Buy, Sell, or Hold Post Q1 Earnings?
Yahoo - 2026-05-19
FDA Accepts Viatris' NDA for Fast-Acting Non-Opioid Pain Therapy
Yahoo - 2026-05-19
1 Stock Under $50 to Target This Week and 2 We Avoid
Yahoo - 2026-05-18
This Income Fund Just Completely Exited Its $37 Million Stake in Algonquin Power. Why?
Yahoo - 2026-05-18
5 Revealing Analyst Questions From Viatris’s Q1 Earnings Call
Yahoo - 2026-05-18
U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain
Benzinga - 2026-05-18
Viatris' New Drug Application For Moderate-To-Severe Acute Pain Treatment Receives FDA's Acceptance For Review
Yahoo - 2026-05-15
Does Strong Q1 Results And CFO Transition Change The Bull Case For Viatris (VTRS)?
Yahoo - 2026-05-13
3 Unprofitable Stocks That Fall Short
SeekingAlpha - 2026-05-13
Novo Nordisk: Why A P/E Of 13 Is A Value Trap, Not A Bargain
SeekingAlpha - 2026-05-12
Viatris Inc. (VTRS) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Finnhub - 2026-05-12
Transcript : Viatris Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 08
SeekingAlpha - 2026-05-12
Viatris: From Cost Story To Pipeline-Driven Re-Rating (Rating Upgrade)
Yahoo - 2026-05-11
VTRS Q1 Deep Dive: China Strength, R&D Pipeline, and Execution Drive Outperformance
SeekingAlpha - 2026-05-11
Viatris: The Cigar Butt Got Smoked, But I'm Holding The Rating
SeekingAlpha - 2026-05-08
Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio - Q1 2026 Update
Yahoo - 2026-05-08
TBPH Q1 Earnings Beat Amid Strategic Restructuring & Pipeline Hurdle
Benzinga - 2026-05-08
RFK Jr. Wants Fewer Americans On Antidepressants — Here's Why The Debate Is Exploding
Benzinga - 2026-05-08
JP Morgan Maintains Neutral on Viatris, Raises Price Target to $18
Benzinga - 2026-05-08
Truist Securities Maintains Buy on Viatris, Raises Price Target to $20
Benzinga - 2026-05-08
Valneva Announces HSR Clearance For Lyme Vaccine Collaboration With Pfizer
Benzinga - 2026-05-08
'Health Officials Close To U.S. Secretary Kennedy Explored Ban Of Some Widely Used Antidepressants' - Reuters Exclusive
Yahoo - 2026-05-07
Viatris Inc. Q1 2026 Earnings Call Summary
Yahoo - 2026-05-07
Assessing Viatris (VTRS) Valuation After Its Recent Share Price Rebound
Yahoo - 2026-05-07
Viatris (VTRS) Q1 2026 Earnings Transcript
Yahoo - 2026-05-07
Viatris Q1 EPS Beats Estimates, Revenues up 8% Driven by Greater China
ChartMill - 2026-05-07
These S&P500 stocks have an unusual volume in today's session
ChartMill - 2026-05-07
What's going on in today's session: S&P500 gap up and gap down stocks
SeekingAlpha - 2026-05-07
Viatris Inc. (VTRS) Q1 2026 Earnings Call Transcript
Yahoo - 2026-05-07
Here's What Key Metrics Tell Us About Viatris (VTRS) Q1 Earnings
Yahoo - 2026-05-07
Viatris (VTRS) Q1 Earnings and Revenues Surpass Estimates
ChartMill - 2026-05-07
Viatris (NASDAQ:VTRS) Shares Rise as Q1 Earnings Top Estimates
Yahoo - 2026-05-07
Viatris’s (NASDAQ:VTRS) Q1 CY2026: Beats On Revenue
Yahoo - 2026-05-07
Viatris Reports First-Quarter 2026 Financial Results
Finnhub - 2026-05-07
Transcript : Viatris Inc., Q1 2026 Earnings Call, May 07, 2026
Finnhub - 2026-05-07
Viatris Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
Finnhub - 2026-05-07
Viatris beats first-quarter estimates on China strength, branded drug sales
SeekingAlpha - 2026-05-07
Viatris Inc. 2026 Q1 - Results - Earnings Call Presentation
Benzinga - 2026-05-07
Viatris Affirms FY2026 Adj EPS Guidance of $2.33-$2.47 vs $2.44 Est; Affirms FY2026 Sales Guidance of $14.450B-$14.950B vs $14.638B Est
Finnhub - 2026-05-07
Viatris : VTRS Q1 2026 Non-GAAP Reconciliations - FINAL
Finnhub - 2026-05-07
Viatris : VTRS Q1 2026 Earnings Presentation - FINAL
Finnhub - 2026-05-07
Viatris : VTRS Q1 2026 Earnings Infographic - FINAL
Finnhub - 2026-05-07
Viatris: Q1 Earnings Snapshot
Benzinga - 2026-05-07
Viatris Q1 Adj. EPS $0.59 Beats $0.50 Estimate, Sales $3.510B Beat $3.357B Estimate
Yahoo - 2026-05-06
Exploring Analyst Estimates for Viatris (VTRS) Q1 Earnings, Beyond Revenue and EPS
Yahoo - 2026-05-06
Are Wall Street Analysts Bullish on Viatris Stock?
Yahoo - 2026-05-05
Viatris Gears Up to Report Q1 Earnings: What's in the Cards?
Yahoo - 2026-05-05
Edwards names Theodora Mistras as CFO
Yahoo - 2026-05-04
Edwards Lifesciences Announces Appointment of CFO
Yahoo - 2026-05-04
Viatris Announces Chief Financial Officer Transition
Benzinga - 2026-05-04
Viatris Appoints Chief Accounting Officer Paul Campbell As Interim CFO, Effective May 8, Succeeding Theodora Mistras
Yahoo - 2026-05-03
Is It Too Late To Consider Viatris (VTRS) After Its Strong One Year Share Price Run
Yahoo - 2026-04-30
Is Viatris (VTRS) One of the Best Medical Stocks to Buy Under $30?
Yahoo - 2026-04-30
Viatris (VTRS) Earnings Expected to Grow: Should You Buy?
SeekingAlpha - 2026-04-29
24 Ideal 'Safer' April Buys Nabbed In 10 Years Of Dogcatcher Digging
Yahoo - 2026-04-23
Viatris' Q1 2026 Earnings: What to Expect
Yahoo - 2026-04-18
Natera, UFP Technologies, Mettler-Toledo, and Viatris Shares Are Soaring, What You Need To Know
Yahoo - 2026-04-16
QSM Asset Management Loads Up 611,000 Mobileye Shares
Yahoo - 2026-04-16
Theravance Stock Declines Around 17% in Three Months: Here's Why
Benzinga - 2026-04-16